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From the Sir George E Clark Metabolic Unit, Royal Victoria Hospital, Belfast BTl2 6BA, Northern Ireland, UK SUMMARY. There has been considerable interest in the serum fructosamine assay as a measure of glycated serum proteins. We have measured serum fructosamine in three groups of patients-those with uraemia; those with multiple myeloma; and those with acute inflammatory conditions-none of whom were known to have diabetes. Serum fructosamine was significantly higher in the uraemic group than in the other two, and also than in a control group. When allowance was made for prevailing serum albumin levels fructosamine was shown to be increased in the acute inflammatory group also. There was a significant correlation between random plasma glucose and serum fructosamine only when fructosamine was adjusted for prevailing albumin levels.
In control and uraemic subjects there was a significant positive correlation between serum fructosamine and albumin levels, whereas in the myeloma group there was a negative correlation with serum protein.
These data would suggest the need to take into account serum albumin levels and protein composition if serum fructosamine is accurately to reflect short-term integrated glycaemia.
Assessment of glycaemic control has always posed a problem in the management and care of patients with insulin-dependent diabetes. Laboratory measurement of plasma glucose is reliable and objective, but because glucose levels can fluctuate widely in these patients, a single measurement can be extremely misleading as to the state of overall glycaemia. Self-monitoring of blood glucose using reagent strips, if performed regularly, can provide a more composite picture, but both the performance and reporting of these tests by the patient may not be truly objective. 1 Measurement of glycated haemoglobin was innovative in providing an objective, quantitative, and retrospective index of integrated glycaemia over a period of time corresponding to the half-life of the red blood cell,2.3 and served as a model for nonenzymatic glycation of other proteins. Nonenzymatically glycated serum proteins reflect integrated glycaemia over a much shorter period of time since serum proteins have shorter halflives than haemoglobin.v" The fructosamine assay is a simple colorimetric method of measuring glycated serum proteins.P The assay is rapid, Correspondence: Dr L Kennedy.
inexpensive and reproducible and has obvious potential clinical application." 13 There is excellent correlation between serum fructosamine and glycated serum proteins measured by affinity chromatography. [14] [15] The fructosamine assay is performed using whole serum and it is pertinent, therefore, to investigate the effect of serum protein concentrations on the measurement and interpretation of fructosamine. This is particularly relevant since a not insignificant proportion of diabetic patients may be expected to develop abnormalities of protein turnover as part of a nephropathic state. We have evaluated the fructosamine assay in three groups of patients-those with uraemia, multiple myeloma, and acute inflammatory conditions-in which abnormalities of serum proteins are known to exist.
Patients and methods
Details of the four groups studied are given in Table I . The control group comprised healthy laboratory and medical staff, and a small number of patients, otherwise well, who were in hospital Glucose (mmol/L) for minor surgical procedures. None of these were known to have diabetes nor a family history of diabetes. In Group 2 the underlying cause of uraemia was thought to be chronic glomerulonephritis or membranoproliferative nephritis in 7 patients, hypertensive nephropathy in 5, chronic pyelonephritis in 3 and there was one case of each of the following: polycystic kidneys; nephrocalcinosis; familial nephritis; immune complex nephritis; and nephropathy related to non-steroidal anti-inflammatory drug therapy. At the time of investigation none of them was receiving dialysis. The diagnosis of multiple myeloma had been confirmed histologically in every patient in Group 3. Seventeen patients in Group 4 had active rheumatoid arthritis, one had seronegative polyarthropathy and one had temporal arteritis. All had an elevated erythrocyte sedimentation rate and C-reactive protein at the time of study.
Non-fasting blood samples were obtained by venepuncture. Serum fructosamine (Cobas Bio; Roche Products, Welwyn Garden City, Herts, UK) was measured as described by Johnston et al.,7 except that the pH of the carbonate buffer was 10·35. Our normal range is 2·0-2·8 mmol/L with a within-assay coefficient of variation (CY) of ±2% and between-assay CYof ±4%. Simul- • P<0·05,·· P<O·OI, t P<O·OOI, compared to control subjects. taneous estimation of serum albumin was made using a bromocresol green technique with a CV of ±2·9% at a mean of 44 giL (linear range 0-80 g/L), A fructosamine/alburnin index (FAI) was derived from the formula (fructosamine, mmol/L) x lOO/(albumin, g/L) as described previously." Glycated haemoglobin was measured using densitometry following agar gel electrophoresis (Coming Medical, Halstead, Essex, UK) after erythrocytes had been incubated in saline to remove labile glycated haemoglobin, and results were expressed as % HbA). 17 The normal range in our laboratory is 3·7-7·2%. The CV within-assay is ± 1·6% and between-assay ±6·4%. Serum urea, creatinine and total protein were measured on a Parallel Analyser (American Monitor (UK) Ltd, Burgess Hill, West Sussex, UK). The CVs for urea were ±2'5% and ±2·3% at meansof4·5 and 14·1 mmol/L respectively (linear range 0-30 mrnol/L); for creatinine ± 2·7% and ± 1·2% at means of 96 and 375 J.lmol/L respectively (linear range 0-2000 J.lmol/L); and for total protein ± 2·1 % at 52 and 83 giL respectively (linear range 0-120 g/L), Plasma glucose was estimated by a glucose oxidase method with CVs of ± 2·6% and ± 1·3% at means of 4·9 and 14·7 mrnol/L respectively (0-50 mmol/L), Comparisons between groups were made using Student's t-test, and correlations were performed by linear regression analysis.
Results
Concentrations of the various analytes measured in each group are shown in Table 2 . Mean serum glucose was elevated in patients with uraemia and acute inflammatory conditions when compared to control subjects. Serum fructosamine was significantly increased in the uraemic patients, but not in the patients with acute inflammatory conditions. In the latter group serum albumin was considerably lower than in control subjects, so that the calculated fructosamine albumin index in the patients with acute inflammatory conditions was significantly greater than that in control subjects. It will be noted also that albumin concentrations were decreased in the uraemic group, and calculation of the fructosamine/albumin index led to a more highly significant difference between those groups than with the uncorrected serum fructosamine. Serum glucose and fructosamine, and fructosamine/albumin index were similar in the myeloma and control groups.
HbA 1 was significantly increased in patients with uraemia and with myeloma. There was no correlation between serum fructosamine and HbA 1 nor between fructosamine/albumin index and HbA 1 , when the groups were considered individually or collectively.
Within each of the four groups there was no significant correlation between the glucose and . .
· .
· · · --· -. · . fructosamine levels or glucose and fructosaminej albumin index. When results from the four groups were amalgamated (Fig. Ia) there was still no significant correlation between serum glucose and fructosamine, but there was a highly significant correlation between serum glucose and fructosaminejalbumin index (Fig. Ib) . Fig. 2 illustrates that in the control group serum fructosamine correlated significantly with the albumin but not total protein concentrations. The same was also true in the group with uraemia (data not shown), whereas in the myeloma group (Fig. 3) there was a positive correlation between serum fructosamine and albumin (P < 0·0 I) and a negative correlation (P> 0,05) between serum fructosamine and total protein. There was no significant correlation between serum fructosamine and albumin or total protein in the acute inflammatory group.
Discussion
The simplicity, rapidity and reproducibility of the fructosamine reaction make it extremely attractive as an assay of glycated serum proteins. The fructosamine assay is performed On whole serum and results are expressed as mmoljL, thereby taking no account of variation in serum albumin or protein concentration. It has been suggested that, in practice, this is of little consequence, except when there is severe hypoalbuminaemia.9.13.18 Glycation of albumin accounts for approximately 90% of the total serum protein glycation," and the results of the present study demonstrate that the serum albumin concentration, even within the normal range, is an important determinant of serum fructosamine.
That this is the case is shown by the correlation between serum fructosamine and albumin in the control group, and in patients with uraemia and myeloma. The negative correlation between serum fructosamine and total protein concentration in the myeloma group can be explained by the fact that the most extreme elevations of serum protein are due to an increase of globulin at the expense of albumin.
Since mean plasma glucose was higher in the patients with uraemia and with acute inflammatory conditions, it might be expected that those groups would have a higher serum fructosamine than control subjects. Because of the lower albumin levels in the acute inflammatory group the difference in glycated serum protein, as reflected by fructosamine, between that group and control subjects was not apparent until the albumin concentration was taken into account by calculation ofthe fructosaminejalbumin index. In the uraemic group, calculation of the index served to accentuate the elevation of glycated serum proteins already apparent through measurement of the uncorrected fructosamine. If, indeed, measurement of fructosamine provides an index of integrated glycaemia over a relatively short period oftime, it may be expected that one would find a correlation between fructosamine levels and serum glucose. However, in the present study, this was true only for the fructosaminej albumin index (Fig. I) again highlighting the importance of adjusting the fructosamine level for the prevailing albumin concentration.
It has long been recognised that HbA I levels may be increased in patients with uraemia. In uraemia there may be impairment of glucose tolerance, as is suggested in the present study by the raised plasma glucose levels, so that the raised HbA I seen in our uraemic patients may, at least in part, reflect a degree of chronic glucose intolerance. It is also known that carbamylation of haemoglobin leads to the formation of a haemoglobin fraction which is indistinguishable from glycated haemoglobin when measured as HbA 1 . 20 The normal HbA I levels seen in the group with acute inflammatory conditions, taken along with the elevated serum glucose and fructosamine/ albumin index levels, would suggest that in these patients there may be a mild 'stress hyperglycaemia', associated with the acute illness.
We have no ready explanation for the raised HbA I levels seen in the myeloma group. Since serum glucose, fructosamine, and fructosarnine/ albumin index were not significantly different from the control subjects we feel it is unlikely that these patients had otherwise undetected impaired glucose tolerance, although in the absence of glucose tolerance tests we cannot be certain of that. It is recognised that in patients who are anaemic spuriously high levels of HbA I may be found with the agar gel electrophoresis method unless adjustments are made, during preparation of the haemolysate, for the lower haemoglobin concentrations." This may have contributed to the raised HbA1 levels in these patients, and also in those with uraemia.
Since serum fructosamine measurement will have its principal use in the assessment of glycaemic control in patients with well established diabetes, it might be argued that the effects of albumin concentration-which appear important when glucose tolerance may be impaired minimally or not at all-may be rendered irrelevant by the much greater effect of hyperglycaemia. However, two recent papers have indicated that in some situations short-term fluctuations in serum protein levels in diabetic patients mean that within a matter of hours the measured serum fructosamine can vary by as much as 10-12% in an individual patient, to a degree negating its value as a measure of average glycaemia unless correction is made for the protein levels.P-" We believe that the data presented in this study represent further evidence of the importance of correcting serum fructosamine for prevailing albumin levels if it is accurately to reflect shortterm integrated glycaemia.
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